Shin Nippon Biomedical Laboratories (FRA:YB3) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 09, 2026)


FRA:YB3 Shin Nippon Biomedical Laboratories Ltd FRA:YB3
74 GF Score
Price €6.95
GF Value €9.41
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Shin Nippon Biomedical Laboratories's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

FRA:YB3 vs TMO, DHR, IDXX: Margin of Safety % (DCF Dividends Based) Comparison

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shin Nippon Biomedical Laboratories Margin of Safety % (DCF Dividends Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Margin of Safety % (DCF Dividends Based) falls into.


FRA:YB3
74GF Score
Shin Nippon Biomedical Laboratories Ltd FRA:YB3
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shin Nippon Biomedical Laboratories (FRA:YB3) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of €6.95 is trading 26.1% below its estimated GF Value™ of €9.41.

Key valuation signals for FRA:YB3:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: €9.41 vs. price of €6.95 (26.1% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the FRA:YB3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
74GF Score

Get the complete analysis for FRA:YB3

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.95
Price
€9.41
GF Value